Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Undesirable side effects in thrombolytic therapy]

G Claus1, D C Gulba

  • 1Franz-Volhard-Klinik, Universitätsklinikums Rudolf Virchow, Freie Universität Berlin.

Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|June 1, 1993
PubMed
Summary

Thrombolytic therapy, despite new drugs, carries risks like severe bleeding and side effects. Careful risk-benefit assessment is crucial before initiating treatment to ensure patient safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Non-vitamin K dependent oral anticoagulants : What is important in intensive care medicine].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2017
Same author

ULTRASTRUCTURAL STUDIES ON THE CYANELLES OF GLAUCOCYSTIS NOSTOCHINEARUM ITZIGSOHN(1).

Journal of phycology·2016
Same author

[Triple therapy for patients with stent and atrial fibrillation? Yes!].

Deutsche medizinische Wochenschrift (1946)·2013
Same author

Degradation of indole by Alcaligenes spec.

Systematic and applied microbiology·2012
Same author

[Coronary artery disease--relevance of total coronary revascularization on the incidence of malignant arrhythmias].

Herzschrittmachertherapie & Elektrophysiologie·2007
Same author

[Postoperative antithrombotic treatment in diabetic patients].

Clinical research in cardiology : official journal of the German Cardiac Society·2006

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Thrombolytic therapy is vital for treating thrombotic events.
  • Newer fibrin-specific plasminogen activators aim to improve efficacy.
  • Significant side effects, including life-threatening hemorrhage, persist.

Purpose of the Study:

  • To review the side effect profile of thrombolytic therapy.
  • To emphasize the importance of risk-benefit analysis in clinical practice.

Main Methods:

  • Literature review of thrombolytic therapy side effects.
  • Analysis of factors influencing bleeding incidence and severity.

Main Results:

  • Bleeding risk escalates with treatment intensity and duration.
  • Side effects include allergic reactions, systemic fibrinogen breakdown, and disease-specific complications.
  • Hemorrhage remains a severe, potentially fatal complication.

Conclusions:

  • Thrombolytic therapy presents a double-edged sword due to inherent risks.
  • Careful consideration of risks versus benefits is essential prior to initiating thrombolysis.

Related Experiment Videos